Global Blood Preparation Market Size, Share, and COVID-19 Impact Analysis, By Product (Whole Blood, Blood Components, Blood Derivatives), By Type (Antithrombotic and Anticoagulant), By Application (Blood and Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

Industry: Healthcare

RELEASE DATE Mar 2024
REPORT ID SI3953
PAGES 200
REPORT FORMAT PathSoft

Global Blood Preparation Market Insights Forecasts to 2033.

  • The Global Blood Preparation Market Size was Valued at USD 46.15 Billion in 2023
  • The Market Size is Growing at a CAGR of 6.01% from 2023 to 2033
  • The Worldwide Blood Preparation Market Size is Expected to Reach USD 82.75 Billion by 2033
  • Asia-Pacific Market is expected to grow the fastest during the forecast period

Global Blood Preparation Market

Get more details on this report -

Request Free Sample PDF

The Global Blood Preparation Market Size is anticipated to exceed USD 82.75 Billion by 2033, Growing at a CAGR of 6.01% from 2023 to 2033.  

 

Market Overview

Blood is the vital liquid organ of the body that functions as an oxygen and nutrients carrier to the cells and takes away their waste products. Blood product is derived from human blood donations for therapeutical uses. It comprises whole blood which is a mixture of cells, colloids, and crystalloids that can be separated into different blood components namely packed red blood cell (PRBC) concentrate, platelet concentrate, fresh frozen plasma, and cryoprecipitate. Because various blood components have distinct relative densities, sedimentation rates, and sizes, they are separated using centrifugation procedures. These blood components are used for different therapeutic uses and have different storage conditions and temperature requirements for therapeutic efficacy. These are therapeutically used for transfusion, and plasma-derived medicinal products. Blood products such as RBCs, fresh frozen plasma (FFP), platelets, and cryoprecipitate are primarily used in transfusion therapy to improve tissue oxygenation in anemia and acute blood loss during trauma or surgery. While FFP, platelets, and cryoprecipitate are used for the prevention and treatment of bleeding. Thus, blood products are medical therapeutics products that play an important role in the healthcare sector. The blood product derived from human blood is modified as leukoreduced products, irradiated products, volume-reduced products, saline-washed products, and pathogen-inactivated products. Several R&D and awareness regarding blood transfusion give a better understanding of blood and its components that is anticipated to create promising opportunities for the blood preparation market.

 

Report Coverage

This research report categorizes the market for the global blood preparation market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global blood preparation market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global blood preparation market.

 

Global Blood Preparation Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023:USD 46.15 Billion
Forecast Period:2023-2033
Forecast Period CAGR 2023-2033 :6.01%
2033 Value Projection:USD 82.75 Billion
Historical Data for:2019-2022
No. of Pages:200
Tables, Charts & Figures:110
Segments covered:By Product, By Type, By Application, By Region
Companies covered:: Pfizer, Inc., Sanofi, AstraZeneca plc, Baxter International Inc., GlaxoSmithKline, Leo Pharma A/S, Portola Pharmaceuticals, Inc., Bristol-Myres Squibb Company, Xiamen Hisunny Chemical Co., Ltd., Shandong East Chemical Industry Co., Portola Pharmaceuticals, Inc., Celgene Corp., Boehringer Ingelheim, Aralez Pharmaceuticals, and Other Key Vendors.
Pitfalls & Challenges:COVID-19 Empact,Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The increasing need for blood transfusion due to the rising number of blood disorders and surgical procedures in hospitals enhances the market demand for blood preparations. Additionally, the advancement in technology for blood component separation is expected to drive the market. The rising development of new high-speed technologies and instruments for blood component preparation is likely to grow the market for blood preparation. The rising prevalence rate of the geriatric population suffering from blood-associated disorders such as anemia or blood clotting demands blood transfusion which in turn increases market growth of blood preparations. 

 

Restraining Factors

The several risk factors associated with blood transfusion such as transmission of viral diseases and allergic reactions such as hypotensive transfusion reaction negatively affect the blood preparation market. In addition, higher production and procurement costs required for the development of advanced forms of blood collection devices are likely to impede the market.

 

Market Segmentation

The Global Blood Preparation Market share is classified into product, type, and application.

  • The whole blood segment is expected to hold the largest share of the global blood preparation market during the forecast period.   

Based on the product, the global blood preparation market is divided into whole blood, blood components, and blood derivatives. Among these, the whole blood segment is expected to hold the largest share of the global blood preparation market during the forecast period. The rising number of major surgeries with accessibility, affordability, and easy maintenance of whole blood segment rising the market demand for global blood preparation. According to givingblood.org, approximately 4.5 million American population need transfusion per year to deal with various healthcare conditions.

 

  • The anticoagulant segment is expected to grow at the fastest pace in the global blood preparation market during the forecast period.    

Based on the type, the global blood preparation market is divided into antithrombotic and anticoagulant. Among these, the anticoagulant segment is expected to grow at the fastest pace in the global blood preparation market during the forecast period. The anticoagulants segment held a share of 66.20% of the blood preparation in 2022. The introduction of new products and the increasing prevalence of cardiac conditions increase the anticoagulant market segment. With ongoing R&D activities, the anticoagulants market is expected to witness substantial growth in the coming years, offering improved therapeutic options for patients at risk of clotting disorders.

 

  • The blood and blood components bank segment is expected to grow at the greatest pace in the global blood preparation market during the forecast period.

Based on the application, the global blood preparation market is divided into blood and blood component bank, diagnostic laboratories, ambulatory surgical centers, and others. Among these, the blood and blood component bank segment is expected to grow at the greatest pace in the global blood preparation market during the forecast period. A large number of blood donations are received by blood banks. The rising demand for blood banks is responsible for increasing the blood preparation market. Blood banks are majorly responsible for the safe storage of blood donations and the process and screening of blood.

 

Regional Segment Analysis of the Global Blood Preparation Market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the global Blood Preparation market over the predicted timeframe.

North America

Get more details on this report -

Request Free Sample PDF

North America is anticipated to hold the largest share of the global blood preparation market over the predicted timeframe. The rising prevalence rate of blood-associated diseases like leukemia, cardiovascular disease, and neurological diseases increasing the blood preparation market in the region. There are approximately 59,610 new cases of leukemia and 23,710 deaths due to leukemia in the U.S. region according to the estimation of the American Cancer Society. The growing patient awareness and increasing healthcare expenditure level of blood transfusion therapeutics are likely to propel the blood preparation market in the region.

 

Asia-Pacific is expected to grow at the fastest pace in the global blood preparation market during the forecast period. The improvement in healthcare infrastructure, presence of untapped opportunities, economic development, and rising initiatives by government and private organizations are some of the key factors responsible for the market growth of blood preparation in the region. The launch of new therapies by active market players creates a favorable market opportunity for the growth of the blood preparation market.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global blood preparation along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Pfizer, Inc.
  • Sanofi
  • AstraZeneca plc
  • Baxter International Inc.
  • GlaxoSmithKline
  • Leo Pharma A/S
  • Portola Pharmaceuticals, Inc.
  • Bristol-Myres Squibb Company
  • Xiamen Hisunny Chemical Co., Ltd.
  • Shandong East Chemical Industry Co.
  • Portola Pharmaceuticals, Inc.
  • Celgene Corp.
  • Boehringer Ingelheim
  • Aralez Pharmaceuticals
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Recent Developments

  • In May 2023, NYBC Ventures launched a $ 50 million fund to accelerate innovations in blood and cellular therapies.

 

  • In February 2023, Terumo blood and cell technologies’ IMUGARD platelet pooling set was cleared by FDA. IMUGUARD is the platelet polling set that supports the extended shelf life of whole blood-derived platelets from five days to seven days.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Blood Preparation Market based on the below-mentioned segments: 

 

Global Blood Preparation Market, By Product

  • Whole blood
  • Blood components
  • Blood derivatives

 

Global Blood Preparation Market, By Type

  • Antithrombotic
  • Anticoagulant

 

Global Blood Preparation Market, By Application

  • Blood and Blood component bank
  • Diagnostic Laboratories
  • Ambulatory surgical centers
  • Others

 

Global Blood Preparation Market, By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions (FAQ)

  • 1. Which are the key companies that are currently operating within the market?
    Pfizer, Inc., Sanofi, AstraZeneca plc, Baxter International Inc., GlaxoSmithKline, Leo Pharma A/S, Portola Pharmaceuticals, Inc., Bristol-Myres Squibb Company, Xiamen Hisunny Chemical Co., Ltd., Shandong East Chemical Industry Co., Portola Pharmaceuticals, Inc., Celgene Corp., Boehringer Ingelheim, Aralez Pharmaceutical, and Others.
  • 2. What is the size of the global Blood Preparation market?
    The Global Blood Preparation Market is expected to grow from USD 46.15 Billion in 2023 to USD 82.75 Billion by 2033, at a CAGR of 6.01% during the forecast period 2023-2033.
  • 3. Which region is holding the largest share of the market?
    North America is anticipated to hold the largest share of the global blood preparation market over the predicted timeframe.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies